📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Vita 34

1.1 - Company Overview

Vita 34 Logo

Vita 34

Headquarter: Germany
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of stem cell services in Europe, including collection, processing, storage, preservation, and retrieval of stem cells from umbilical cord blood and tissue. Offerings include VitaMine&Yours for umbilical cord tissue preparation for cryo-preservation and VitaPlusDonation for personal stem cell deposits for healthcare use.

Products and services

  • Stem Cell Preservation: Cryogenic preservation of umbilical cord-derived stem cells to maintain long-term viability for future therapeutic applications, ensuring readiness for medical treatments when needed
  • Stem Cell Processing: Laboratory-grade preparation of collected umbilical cord stem cells and tissue using VitaMine&Yours, readying tissue for cryo-preservation and future medical use
  • Stem Cell Storage: Cryogenic, personal deposit storage of umbilical cord blood and tissue-derived stem cells collected at birth, via VitaPlusDonation, held for personal health care use

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Vita 34

IBL International Logo

IBL International

HQ: Germany Website
  • Description: Provider of immunoassays and antibodies/in-vitro diagnostic assays for research, clinical, and specialty laboratories; develops, manufactures, and distributes assays focused on special and rare indications in endocrinology, neonatal screening, and the diagnosis of stress parameters and steroid hormones.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full IBL International company profile →
Scireq Logo

Scireq

HQ: Canada Website
  • Description: Provider of laboratory equipment for preclinical respiratory research.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Scireq company profile →
Breath Therapeutics Logo

Breath Therapeutics

HQ: Germany Website
  • Description: Provider of inhaled investigational therapies for rare respiratory diseases, combining novel formulations of existing drugs with cutting-edge inhalation technology. Pipeline includes Liposomal Cyclosporine A for Inhalation for bronchiolitis obliterans syndrome to deliver drug to lungs while minimizing systemic exposure, and inhaled colistimethate sodium for non-cystic fibrosis bronchiectasis targeting Pseudomonas aeruginosa.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Breath Therapeutics company profile →
Arzeda Logo

Arzeda

HQ: United States Website
  • Description: Provider of AI-driven protein and enzyme design and manufacturing for pharmaceuticals, industrial chemicals, and food applications. Offers Intelligent Protein Design Technology to create novel proteins; ProSweet enzymes for efficient production of Reb D and Reb M from stevia; and collaborates with Unilever (cleaning), W. L. Gore (materials), Takeda (therapeutic biologics), and AAK (plant-based oils).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arzeda company profile →
Caliper Life Sciences Logo

Caliper Life Sciences

HQ: United States Website
  • Description: Provider of integrated systems consisting of instruments, software and reagents, laboratory automation tools, and assay and discovery services for pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions worldwide.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Caliper Life Sciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Vita 34

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Vita 34

2.2 - Growth funds investing in similar companies to Vita 34

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Vita 34

4.2 - Public trading comparable groups for Vita 34

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Vita 34

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Vita 34

What does Vita 34 do?

Vita 34 is a provider of stem cell services in Europe, including collection, processing, storage, preservation, and retrieval of stem cells from umbilical cord blood and tissue. Offerings include VitaMine&Yours for umbilical cord tissue preparation for cryo-preservation and VitaPlusDonation for personal stem cell deposits for healthcare use.

Who are Vita 34's competitors?

Vita 34's competitors and similar companies include IBL International, Scireq, Breath Therapeutics, Arzeda, and Caliper Life Sciences.

Where is Vita 34 headquartered?

Vita 34 is headquartered in Germany.

How many employees does Vita 34 have?

Vita 34 has 1,000 employees 🔒.

When was Vita 34 founded?

Vita 34 was founded in 2010 🔒.

What sector and industry vertical is Vita 34 in?

Vita 34 is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Vita 34

Who are the top strategic acquirers in Vita 34's sector and industry

Top strategic M&A buyers and acquirers in Vita 34's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Vita 34?

Top strategic M&A buyers groups and sectors for Vita 34 include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Vita 34's sector and industry vertical

Which are the top PE firms investing in Vita 34's sector and industry vertical?

Top PE firms investing in Vita 34's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Vita 34's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Vita 34's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Vita 34's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Vita 34 include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Vita 34's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Vita 34?

The key public trading comparables and valuation benchmarks for Vita 34 include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Vita 34 for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Vita 34 with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Vita 34's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Vita 34 with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Vita 34's' sector and industry vertical?

Access recent funding rounds and capital raises in Vita 34's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Vita 34

Launch login modal Launch register modal